5-Lipoxygenase-activating protein (FLAP) inhibitors

5-Lipoxygenase-activating protein (FLAP) inhibitors

5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP) Also described herein are 5 methods of using such FLAP modulators, alone and in combin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROPPE, JEFFREY ROGER, PRASIT, PETPIBOON PEPPI, LI, YIWEI, ZUNIC, JASMINE ELEANOR, HADDACH, MUSTAPHA, MORAN, MARK, STOCK, NICHOLAS SIMON, HUTCHINSON, JOHN HOWARD, STEARNS, BRIAN ANDREW, ARRUDA, JEANNIE M, EVANS, JILLIAN F
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ROPPE, JEFFREY ROGER
PRASIT, PETPIBOON PEPPI
LI, YIWEI
ZUNIC, JASMINE ELEANOR
HADDACH, MUSTAPHA
MORAN, MARK
STOCK, NICHOLAS SIMON
HUTCHINSON, JOHN HOWARD
STEARNS, BRIAN ANDREW
ARRUDA, JEANNIE M
EVANS, JILLIAN F
description 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP) Also described herein are 5 methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotrien.e mediated conditions c-r diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2010241356BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2010241356BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2010241356BB23</originalsourceid><addsrcrecordid>eNrjZDA21fXJLMivqExPzUssTtVNTC7JLEssycxLVygoyi9JzcxT0HDzcQzQVMjMy8hMyizJLyrmYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoYGRiaGxqZmTk5GxkQqAwDFXy0l</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-Lipoxygenase-activating protein (FLAP) inhibitors</title><source>esp@cenet</source><creator>ROPPE, JEFFREY ROGER ; PRASIT, PETPIBOON PEPPI ; LI, YIWEI ; ZUNIC, JASMINE ELEANOR ; HADDACH, MUSTAPHA ; MORAN, MARK ; STOCK, NICHOLAS SIMON ; HUTCHINSON, JOHN HOWARD ; STEARNS, BRIAN ANDREW ; ARRUDA, JEANNIE M ; EVANS, JILLIAN F</creator><creatorcontrib>ROPPE, JEFFREY ROGER ; PRASIT, PETPIBOON PEPPI ; LI, YIWEI ; ZUNIC, JASMINE ELEANOR ; HADDACH, MUSTAPHA ; MORAN, MARK ; STOCK, NICHOLAS SIMON ; HUTCHINSON, JOHN HOWARD ; STEARNS, BRIAN ANDREW ; ARRUDA, JEANNIE M ; EVANS, JILLIAN F</creatorcontrib><description>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP) Also described herein are 5 methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotrien.e mediated conditions c-r diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110728&amp;DB=EPODOC&amp;CC=AU&amp;NR=2010241356B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110728&amp;DB=EPODOC&amp;CC=AU&amp;NR=2010241356B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROPPE, JEFFREY ROGER</creatorcontrib><creatorcontrib>PRASIT, PETPIBOON PEPPI</creatorcontrib><creatorcontrib>LI, YIWEI</creatorcontrib><creatorcontrib>ZUNIC, JASMINE ELEANOR</creatorcontrib><creatorcontrib>HADDACH, MUSTAPHA</creatorcontrib><creatorcontrib>MORAN, MARK</creatorcontrib><creatorcontrib>STOCK, NICHOLAS SIMON</creatorcontrib><creatorcontrib>HUTCHINSON, JOHN HOWARD</creatorcontrib><creatorcontrib>STEARNS, BRIAN ANDREW</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE M</creatorcontrib><creatorcontrib>EVANS, JILLIAN F</creatorcontrib><title>5-Lipoxygenase-activating protein (FLAP) inhibitors</title><description>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP) Also described herein are 5 methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotrien.e mediated conditions c-r diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDA21fXJLMivqExPzUssTtVNTC7JLEssycxLVygoyi9JzcxT0HDzcQzQVMjMy8hMyizJLyrmYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoYGRiaGxqZmTk5GxkQqAwDFXy0l</recordid><startdate>20110728</startdate><enddate>20110728</enddate><creator>ROPPE, JEFFREY ROGER</creator><creator>PRASIT, PETPIBOON PEPPI</creator><creator>LI, YIWEI</creator><creator>ZUNIC, JASMINE ELEANOR</creator><creator>HADDACH, MUSTAPHA</creator><creator>MORAN, MARK</creator><creator>STOCK, NICHOLAS SIMON</creator><creator>HUTCHINSON, JOHN HOWARD</creator><creator>STEARNS, BRIAN ANDREW</creator><creator>ARRUDA, JEANNIE M</creator><creator>EVANS, JILLIAN F</creator><scope>EVB</scope></search><sort><creationdate>20110728</creationdate><title>5-Lipoxygenase-activating protein (FLAP) inhibitors</title><author>ROPPE, JEFFREY ROGER ; PRASIT, PETPIBOON PEPPI ; LI, YIWEI ; ZUNIC, JASMINE ELEANOR ; HADDACH, MUSTAPHA ; MORAN, MARK ; STOCK, NICHOLAS SIMON ; HUTCHINSON, JOHN HOWARD ; STEARNS, BRIAN ANDREW ; ARRUDA, JEANNIE M ; EVANS, JILLIAN F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2010241356BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ROPPE, JEFFREY ROGER</creatorcontrib><creatorcontrib>PRASIT, PETPIBOON PEPPI</creatorcontrib><creatorcontrib>LI, YIWEI</creatorcontrib><creatorcontrib>ZUNIC, JASMINE ELEANOR</creatorcontrib><creatorcontrib>HADDACH, MUSTAPHA</creatorcontrib><creatorcontrib>MORAN, MARK</creatorcontrib><creatorcontrib>STOCK, NICHOLAS SIMON</creatorcontrib><creatorcontrib>HUTCHINSON, JOHN HOWARD</creatorcontrib><creatorcontrib>STEARNS, BRIAN ANDREW</creatorcontrib><creatorcontrib>ARRUDA, JEANNIE M</creatorcontrib><creatorcontrib>EVANS, JILLIAN F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROPPE, JEFFREY ROGER</au><au>PRASIT, PETPIBOON PEPPI</au><au>LI, YIWEI</au><au>ZUNIC, JASMINE ELEANOR</au><au>HADDACH, MUSTAPHA</au><au>MORAN, MARK</au><au>STOCK, NICHOLAS SIMON</au><au>HUTCHINSON, JOHN HOWARD</au><au>STEARNS, BRIAN ANDREW</au><au>ARRUDA, JEANNIE M</au><au>EVANS, JILLIAN F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-Lipoxygenase-activating protein (FLAP) inhibitors</title><date>2011-07-28</date><risdate>2011</risdate><abstract>5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP) Also described herein are 5 methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotrien.e mediated conditions c-r diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2010241356BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title 5-Lipoxygenase-activating protein (FLAP) inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROPPE,%20JEFFREY%20ROGER&rft.date=2011-07-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2010241356BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true